JAMA

Online Prescribing of Diabetes and Weight Loss Medications

Updated

Abstract

This secret shopper study examines the prescription process for obtaining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) from online sellers.

  • The study reveals variability in the clinical engagement required to obtain GLP-1 RAs online.
  • Different online sellers demonstrate differing levels of adherence to prescription protocols.
  • The findings suggest potential gaps in the oversight of online pharmaceutical practices.
  • Variations in the prescription processes may influence patient access to GLP-1 RAs.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Conflict of Interest Disclosures: Dr Ross reported receiving grants from the FDA, Johnson & Johnson (through the Yale Open Data Access Project), the National Institutes of Health, and the Greenwall Foundation and serving as Deputy Editor of JAMA . Dr Ramachandran reported receiving grants from the Greenwall Foundation, the Stavros Niarchos Foundation, Public Citizen, and the FDA; receiving consulting fees from ReAct-Action and Debevoise and Plimpton LLP; receiving an honorarium from Roosevelt Institute (for participation in the Reimagine America Fellows program); and serving in an unpaid capacity on the board of directors for Doctors for America. No other disclosures were reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free